A research collaboration between Brainomix and AstraZeneca has shown that Brainomix’s AI-powered e-Lung software can more accurately identify lung fibrosis patients most at risk of decline.Brainomix published a study in the peer-reviewed journal ‘American…
Continue Reading
Background: Hypertension significantly impacts the well-being and health of individuals globally. Hypertension management apps (HMAs) have been shown to assist patients in controlling blood pressure (BP), with their efficacy validated in clinical trials. However,…
Continue Reading
Clinical research relies on high-quality patient data, however, obtaining big data sets is costly and access to existing data is often hindered by privacy and regulatory concerns. Synthetic data generation holds the promise of…
Continue Reading
What You Should Know:
– The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC’s oncology care…
Continue Reading
Background: Despite its importance to women’s reproductive health and its impact on women’s daily lives, the menstrual cycle, its regulation, and its impact on health remain poorly understood. As conventional clinical trials rely on…
Continue Reading
By Shania Kennedy
March 07, 2024 – Cedars-Sinai researchers successfully utilized artificial intelligence (AI) to make pathology reports machine-readable, which could improve cancer patient recruitment in clinical trials.
The research team emphasized that cancer patients’ pathology data…
Lantheus Holdings, Inc. celebrates FDA approval for DEFINITY as an ultrasound enhancing agent in pediatric patients with suboptimal echocardiograms. Rigorous clinical trials affirm DEFINITY’s efficacy and safety in this population, marking a significant stride…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
Pioneering AIxSCAN, Inc. introduces the ARC60, an AI-driven tomosynthesis X-ray imaging system poised to revolutionize lung disease diagnosis. Clinical trials demonstrate promising results, igniting anticipation for FDA approval in 2024. Supported by cutting-edge technology…
Continue Reading
